FUJIFILM Opens New Laboratory in North Carolina
PTSM: Pharmaceutical Technology Sourcing and Management
The company opened its 62,000 square foot facility, called the BioProcess Innovation Center, in Triangle Park, NC.
FUJIFILM Diosynth Biotechnologies completed construction on a new three-story, 62,000-square-foot facility in Research Triangle Park, NC. A ribbon cutting ceremony was held on May 9, 2016, the company said in a press announcement. The new building, called BioProcess Innovation Center, houses the company’s Process and Analytical Research and Development, Process Sciences, and Stability groups. These groups will concentrate on process invention, design and development, and process and product characterization. The new facility is located at 6051 George Watts Hill Drive. FUJIFILM Diosynth Biotechnologies also has facilities in Billingham UK, and College Station Texas.
Source: FUJIFILM
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
In Wake of Trump Tariffs, Lilly Plans New US Pharmaceutical Manufacturing Sites
February 26th 2025Previous domestic capital expansion commitments since 2020 had been made in Research Triangle Park and Concord, both in North Carolina; Kenosha County, Wisconsin; Lebanon, Indiana; and Lilly’s home city of Indianapolis.
Cosette Pharmaceuticals Adds to Dermatology and Women’s Health Portfolio with Mayne Pharma Purchase
Published: February 26th 2025 | Updated: February 26th 2025While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of the acquisition.
